Category Archive for: ‘Drug Evaluation’

FDA Approves New Drug to Alleviate Moderate to Severe Pain

FDA NewsNovember 24, 2008 The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. Tapentadol is a centrally-acting synthetic analgesic that is available in doses of 50 mg, 75 mg, or 100 mg. “This approval offers health care professionals an additional choice for treating moderate to severe …

Read More